NEXALIN TECHNOLOGY INC (NXL) Stock News

USA - NASDAQ:NXL - US65345B2016 - Common Stock

0.9349 USD

+0.15 (+18.42%)

Last: 9/19/2025, 8:00:02 PM

0.9131 USD

-0.02 (-2.33%)

After Hours: 9/19/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NXL Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Benzinga - Mentions: EPIX AXGN THAR IPA ...

12 Health Care Stocks Moving In Monday's Intraday Session

a month ago - By: Nexalin Technology, Inc.

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

a month ago - By: Nexalin Technology, Inc.

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

a month ago - By: Benzinga - Mentions: EPIX ONMD AXGN PRTG ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

2 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

2 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

4 months ago - By: ACCESS Newswire - Mentions: FATN

Nexalin and FatPipe Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

4 months ago - By: Nexalin Technology, Inc.

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3

4 months ago - By: Nexalin Technology, Inc.

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3

4 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data

4 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

5 months ago - By: Nexalin Technology, Inc.

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices